Your browser doesn't support javascript.
loading
Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study).
Romero-Laorden, Nuria; Lozano, Rebeca; Jayaram, Anuradha; López-Campos, Fernando; Saez, Maria I; Montesa, Alvaro; Gutierrez-Pecharoman, Ana; Villatoro, Rosa; Herrera, Bernardo; Correa, Raquel; Rosero, Adriana; Pacheco, María I; Garcés, Teresa; Cendón, Ylenia; Nombela, Ma Paz; Van de Poll, Floortje; Grau, Gala; Rivera, Leticia; López, Pedro P; Cruz, Juan-Jesús; Lorente, David; Attard, Gerhardt; Castro, Elena; Olmos, David.
Affiliation
  • Romero-Laorden N; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Lozano R; Medical Oncology Department, Hospital Universitario de La Princesa, Madrid, Spain.
  • Jayaram A; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • López-Campos F; Medical Oncology Department, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Saez MI; CNIO-IBIMA Genitourinary Cancer Research Unit, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • Montesa A; Division of Molecular Pathology, Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.
  • Gutierrez-Pecharoman A; Academic Urology, The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Villatoro R; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Herrera B; Radiation Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Correa R; CNIO-IBIMA Genitourinary Cancer Research Unit, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • Rosero A; Medical Oncology Department, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain.
  • Pacheco MI; CNIO-IBIMA Genitourinary Cancer Research Unit, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • Garcés T; Medical Oncology Department, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain.
  • Cendón Y; Medical Oncology Department, Hospital Universitario de La Princesa, Madrid, Spain.
  • Nombela MP; Pathology Department, Hospital Universitario de Móstoles, Móstoles, Spain.
  • Van de Poll F; CNIO-IBIMA Genitourinary Cancer Research Unit, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • Grau G; Medical Oncology Department, Hospital Costa del Sol, Marbella, Spain.
  • Rivera L; CNIO-IBIMA Genitourinary Cancer Research Unit, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • López PP; Urology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Cruz JJ; CNIO-IBIMA Genitourinary Cancer Research Unit, Institute of Biomedical Research in Málaga (IBIMA), Málaga, Spain.
  • Lorente D; Radiation Oncology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
  • Attard G; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Castro E; Oncology Department, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain.
  • Olmos D; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Br J Cancer ; 119(9): 1052-1059, 2018 10.
Article in En | MEDLINE | ID: mdl-30131546

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dexamethasone / Prednisone / Antineoplastic Agents, Hormonal / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Observational_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dexamethasone / Prednisone / Antineoplastic Agents, Hormonal / Prostatic Neoplasms, Castration-Resistant Type of study: Clinical_trials / Observational_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2018 Document type: Article Affiliation country: Country of publication: